20 February 2024 : Original article
Lymphocele Outcomes After Renal Transplantations Performed by an Experienced Surgeon: Is Meticulously Performed Surgery and Experience Adequate to Prevent Lymphocele?
Nurettin Ay1ABCDEF*, Vahhac Alp1B, Recai Duymuş2BD, Sedat Çetin3BDDOI: 10.12659/AOT.942656
Ann Transplant 2024; 29:e942656
Table 1 Patient, surgical, preoperative, and postoperative variables.
| Characteristic | All patients n=315 | Nonlymphocele group 233 (74%) | Lymphocele group 82 (26%) | P value |
|---|---|---|---|---|
| Age | 33.45±13.8 | 33.47±14 | 33.38±13.3 | 0.96 |
| Sex, n (%) | 0.22 | |||
| Female | 128 (40.6%) | 90 (38.6%) | 38 (46.3%) | |
| Male | 187 (60.4%) | 143 (62.4%) | 44 (53.7%) | |
| <3 cm | 25 (30.5%) | |||
| 3–5.9 cm | 37 (45.1%) | |||
| 6–9.9 cm | 13 (15.9%) | |||
| >10 cm | 7 (8.5%) | |||
| No intervention | 66 (80.5%) | |||
| UGPD | 12 (14.6%) | |||
| UGPD+LF | 4 (4.9%) | |||
| 0.153 | ||||
| Diabetes mellitus | 39 (12.4%) | 30 (12.9%) | 9 (11%) | |
| Hypertension | 96 (30.5%) | 66 (28.3%) | 30 (36.6%) | |
| Urological pathologies | 29 (9.2%) | 25 (10.7%) | 4 (4.9%) | |
| CGN | 42 (13.3%) | 26 (11.2%) | 16 (19.55) | |
| PKCD | 5 (1.6%) | 5 (2.1%) | 0 | |
| NS or NP | 62 (19.7%) | 46 (19.7%) | 16 (19.5%) | |
| Other | 20 (6.3%) | 17 (7.3%) | 3 (3.7%) | |
| Unknown causes | 22 (7%) | 18 (7.7%) | 4 (4.9%) | |
| 0.17 | ||||
| CCF | 204 (64.8%) | 156 (67%) | 48 (58.5%) | |
| Ligation | 111 (35.2%) | 77 (33%) | 34 (41.5%) | |
| UGDP – ultrasound-guided drain placement; ESRD – end-stage renal disease; CGN – chronic glomerulo-nephritis; PKCD – polycystic kidney disease; NS or NP – nephrotic syndrome or nephronophthisis; LF – laparoscopic fenestration; LVC – lymphatic vessel control; CCF – cautery coagulation with forceps. | ||||